Telefonica, the Spanish telecommunications company, has proposed a workforce restructuring plan in Spain that will impact 5,124 jobs as part of its reorganization efforts. The plan, which aims to address organizational, technical, and production needs, was revealed by a spokesperson from trade union UGT to Dow Jones Newswires.

According to Telefonica's 2022 annual report, the company currently employs 20,947 individuals in its home market. While the company is yet to provide a comment on the matter, the spokesperson from UGT mentioned that affected employees may have the opportunity to be relocated to other activities within the company and receive training for other roles.

The employees who will be affected by the workforce adjustment plan are those who were born before 1968 and have been with Telefonica for at least 15 years. However, UGT argues that the actual number of impacted jobs should be considerably lower than the initial estimate.

The negotiations between Telefonica and the unions have already commenced, and the next meeting is scheduled for December 11th.

General Motors Co.’s Stock Rises After UAW Strike

Stock Market Update

Leave A Reply

Your email address will not be published. Required fields are marked *

Related posts

AngioDynamics Reports Profit in Q1
News

AngioDynamics Reports Profit in Q1

AngioDynamics reports a profit of $45.9 million in Q1, driven by the sale of its Dialysis and BioSentry portfolios. Sale...

BlackBerry Announces $160 Million Convertible Senior Notes Offering
News

BlackBerry Announces $160 Million Convertible Senior Notes Offering

BlackBerry announces a $160 million convertible senior notes offering, resulting in a 12% drop in shares.

United Utilities to Invest £13.7 Billion in Waste and Wastewater Infrastructure
News

United Utilities to Invest £13.7 Billion in Waste and Wastewater Infrastructure

United Utilities Group will invest £13.7 billion in waste and wastewater infrastructure, creating new jobs and improving...

Challenges for Hikma Pharmaceuticals in North America
News

Challenges for Hikma Pharmaceuticals in North America

Hikma Pharmaceuticals faces challenges in its injectables business in North America due to supply and capacity constrain...